Congratulation! An 505b1 drug for treating cardiovascular was granted by the US FDA!

Recently, another new achievement was reached by the professional team of Virginia Contract Research Organization Co., Ltd. (VCRO). A startup biotech company, which was assisted by VCRO, was granted 505b1 product for chronic heart failure from the FDA. The professional, integrated, and local team of VCRO helps our customers to achieve the product in the…

min read

Recently, another new achievement was reached by the professional team of Virginia Contract Research Organization Co., Ltd. (VCRO). A startup biotech company, which was assisted by VCRO, was granted 505b1 product for chronic heart failure from the FDA. The professional, integrated, and local team of VCRO helps our customers to achieve the product in the niche of strategy.